Download Author Version (PDF)
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Standards - ST.26 Page: 3.26.1
HANDBOOK ON INDUSTRIAL PROPERTY INFORMATION AND DOCUMENTATION Ref.: Standards - ST.26 page: 3.26.1 STANDARD ST.26 SEPTEMBER 2017 CHANGES MAIN BODY Editorial Note, revised June 2017 - CWS/5 INTRODUCTION, SCOPE, REFERENCES, REPRESENTATION OF SEQUENCES and STRUCTURE OF THE SEQUENCE LISTING IN XML, revised June 2017 - CWS/5 ANNEX I Sections 2, 3, 5, 6, 7, 8 and 9, revised June 2017 - CWS/5 ANNEX II Revised June 2017 - CWS/5 ANNEX III Revised June 2017 - CWS/5 ANNEX VI Added June 2017 - CWS/5 en / 03-26-01 Date: June 2016 September 2017 HANDBOOK ON INDUSTRIAL PROPERTY INFORMATION AND DOCUMENTATION Ref.: Standards - ST.26 page: 3.26.2 STANDARD ST.26 RECOMMENDED STANDARD FOR THE PRESENTATION OF NUCLEOTIDE AND AMINO ACID SEQUENCE LISTINGS USING XML (EXTENSIBLE MARKUP LANGUAGE) Version 1.01.1 Adopted Approved by the Committee on WIPO Standards (CWS) at its reconvened fourth session on March 24, 2016 fifth session on June 2, 2017 Editorial Note prepared by the International Bureau At its fifth session, the Committee on WIPO Standards (CWS) agreed that the transition from WIPO Standard ST.25 to Standard ST.26 takes place in January 2022. Meanwhile, Standard ST.25 should continue to be used. The Committee on WIPO Standards (CWS) agreed to ask industrial property offices to postpone the preparations for implementation of this new WIPO Standard ST.26 until the recommendations for the transition from WIPO Standard ST.25 to the new Standard ST.26 is agreed on by the CWS at its next session to be held in 2017. Meanwhile, Standard ST.25 should continue to be used. -
Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules
MEDICAL INTELLIGENCE UNIT Peptide Nucleic Acids, Morpholinos and Related Antisense Biomolecules Christopher G. Janson, M.D. Departments of Neurosurgery, Neurology and Molecular Genetics Cell and Gene Therapy Center UMDNJ-Robert Wood Johnson Medical School Camden, New Jersey, U.S.A. Matthew J. During, M.D., ScD. Department of Molecular Medicine and Pathology University of Auckland Auckland, New Zealand LANDES BIOSCIENCE / EUREKAH.COM KLUWER ACADEMIC / PLENUM PUBLISHERS GEORGETOWN, TEXAS NEW YORK, NEW YORK USA U.SA PEPTIDE NUCLEIC ACIDS, MORPHOLINOS AND RELATED ANTISENSE BIOMOLECULES Medical Intelligence Unit Landes Bioscience / Eurekah.com Kluwer Academic / Plenum Publishers Copyright ©2006 Eurekah.com and Kluwer Academic / Plenum Publishers All rights reserved. No part of this book may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopy, recording, or any information storage and retrieval system, without permission in writing from the publisher, vdth the exception of any material supplied specifically for the purpose of being entered and executed on a computer system; for exclusive use by the Purchaser of the work. Printed in the U.S.A. Kluwer Academic / Plenum PubHshers, 233 Spring Street, New York, New York, U.S.A. 10013 http ://www.wkap .nl/ Please address all inquiries to the Publishers: Landes Bioscience / Eurekah.com, 810 South Church Street, Georgetown, Texas, U.S.A. 78626 Phone: 512/ 863 7762; FAX: 512/ 863 0081 http ://v^^ww.eurekah. com http://www.landesbioscience.com Peptide -
Expedient Approaches to Bicyclic Nucleosides: Precursors to Nucleic Acid Modifications for Antisense-Based Therapeutics Natasha Narayanan, Ana Dmytrejchuk
Auburn University Journal of Undergraduate Scholarship | SPRING 2016 Auburn University Journal of Undergraduate Scholarship | SPRING 2016 Expedient Approaches to Bicyclic Nucleosides: Precursors to nucleic acid modifications for antisense-based therapeutics Natasha Narayanan, Ana Dmytrejchuk The human race is afflicted by countless Incorporating chemically modified The first and only reported synthesis diseases, many of which have genetic nucleosides in antisense strands has been involves 29 synthetic steps,1 which is origins. Small molecule therapeutics, shown to result in a stronger binding uneconomical in terms of both time and the traditional mode of treatment for interaction between the antisense strand money. In order to solve this problem, our genetic diseases, has focused on targeting and the mRNA, which translates to a more research is focused on the development of the pathogenic protein when it may be effective drug. The modifications we are short, streamlined synthetic approaches more effective to target the messenger interested in are tricyclic nucleic acids to TriNAs. RNA (mRNA) strand that codes for the (TriNAs), so named because the modified protein. This can be accomplished using ribose sugar contains three rings. Antisense The inexpensive ($0.40/gram) and a complementary DNA-based sequence strands that contain TriNAs show a higher commercially available nucleoside known as an antisense strand, which binds thermal stability when bound to mRNA 5-methyluridine (1) was selected as to the mRNA before it is translated into a compared to antisense strands containing the starting material for our synthesis protein. This binding event prevents the other reported modifications. However, a (Figure 1). Following protection with mRNA from undergoing translation, thus major drawback to the use of TriNAs as cyclohexanone dimethyl ketal to obtain inhibiting protein synthesis. -
New Constrained Amino Acids and Peptide Nucleic Acid Building Blocks for the Construction of Bio-Polymers Alexandra Gresika
New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers Alexandra Gresika To cite this version: Alexandra Gresika. New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers. Other. Université Côte d’Azur, 2018. English. NNT : 2018AZUR4104. tel-02073232 HAL Id: tel-02073232 https://tel.archives-ouvertes.fr/tel-02073232 Submitted on 19 Mar 2019 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. THÈSE DE DOCTORAT Nouveaux synthons contraints de type - amino acides et PNA en vue de l´élaboration de bio-foldamères New constrained amino acids and peptide nucleic acid building blocks for the construction of biopolymers Alexandra Gresika Molécules Bioactives Présentée en vue de l’obtention Devant le jury, composé de : du grade de docteur en Chimie Muriel Amblard, Directrice de Recherche d’Université Côte d’Azur CNRS, IBMM UMR 5247, Université de Dirigée par : Nadia Patino Montpellier Karine Alvarez, Chargée de Recherche Soutenue le : 16.11.2018 CNRS, AFBM UMR 7257, Université Aix- Marseille Mohamed Mehiri, Maître de Conférences, ICN UMR 7272, Université Côte d’Azur Nadia Patino, Professeur des Universités, ICN UMR 7272, Université Côte d’Azur 1 New constrained amino acids and peptide nucleic acid building blocks for the construction of bio-polymers. -
Advances in Oligonucleotide Drug Delivery
REVIEWS Advances in oligonucleotide drug delivery Thomas C. Roberts 1,2 ✉ , Robert Langer 3 and Matthew J. A. Wood 1,2 ✉ Abstract | Oligonucleotides can be used to modulate gene expression via a range of processes including RNAi, target degradation by RNase H-mediated cleavage, splicing modulation, non-coding RNA inhibition, gene activation and programmed gene editing. As such, these molecules have potential therapeutic applications for myriad indications, with several oligonucleotide drugs recently gaining approval. However, despite recent technological advances, achieving efficient oligonucleotide delivery, particularly to extrahepatic tissues, remains a major translational limitation. Here, we provide an overview of oligonucleotide-based drug platforms, focusing on key approaches — including chemical modification, bioconjugation and the use of nanocarriers — which aim to address the delivery challenge. Oligonucleotides are nucleic acid polymers with the In addition to their ability to recognize specific tar- potential to treat or manage a wide range of diseases. get sequences via complementary base pairing, nucleic Although the majority of oligonucleotide therapeutics acids can also interact with proteins through the for- have focused on gene silencing, other strategies are being mation of three-dimensional secondary structures — a pursued, including splice modulation and gene activa- property that is also being exploited therapeutically. For tion, expanding the range of possible targets beyond example, nucleic acid aptamers are structured -
Guide for Morpholino Users: Toward Therapeutics
Open Access Journal of Drug Discovery, Development and Delivery Special Article - Antisense Drug Research and Development Guide for Morpholino Users: Toward Therapeutics Moulton JD* Gene Tools, LLC, USA Abstract *Corresponding author: Moulton JD, Gene Tools, Morpholino oligos are uncharged molecules for blocking sites on RNA. They LLC, 1001 Summerton Way, Philomath, Oregon 97370, are specific, soluble, non-toxic, stable, and effective antisense reagents suitable USA for development as therapeutics and currently in clinical trials. They are very versatile, targeting a wide range of RNA targets for outcomes such as blocking Received: January 28, 2016; Accepted: April 29, 2016; translation, modifying splicing of pre-mRNA, inhibiting miRNA maturation and Published: May 03, 2016 activity, as well as less common biological targets and diagnostic applications. Solutions have been developed for delivery into a range of cultured cells, embryos and adult animals; with development of a non-toxic and effective system for systemic delivery, Morpholinos have potential for broad therapeutic development targeting pathogens and genetic disorders. Keywords: Splicing; Duchenne muscular dystrophy; Phosphorodiamidate morpholino oligos; Internal ribosome entry site; Nonsense-mediated decay Morpholinos: Research Applications, the transcript from miRNA regulation; Therapeutic Promise • Block regulatory proteins from binding to RNA, shifting Morpholino oligos bind to complementary sequences of RNA alternative splicing; and get in the way of processes. Morpholino oligos are commonly • Block association of RNAs with cytoskeletal motor protein used to prevent a particular protein from being made in an organism complexes, preventing RNA translocation; or cell culture. Morpholinos are not the only tool used for this: a protein’s synthesis can be inhibited by altering DNA to make a null • Inhibit poly-A tailing of pre-mRNA; mutant (called a gene knockout) or by interrupting processes on RNA • Trigger frame shifts at slippery sequences; (called a gene knockdown). -
De Novo Nucleic Acids: a Review of Synthetic Alternatives to DNA and RNA That Could Act As † Bio-Information Storage Molecules
life Review De Novo Nucleic Acids: A Review of Synthetic Alternatives to DNA and RNA That Could Act as y Bio-Information Storage Molecules Kevin G Devine 1 and Sohan Jheeta 2,* 1 School of Human Sciences, London Metropolitan University, 166-220 Holloway Rd, London N7 8BD, UK; [email protected] 2 Network of Researchers on the Chemical Evolution of Life (NoR CEL), Leeds LS7 3RB, UK * Correspondence: [email protected] This paper is dedicated to Professor Colin B Reese, Daniell Professor of Chemistry, Kings College London, y on the occasion of his 90th Birthday. Received: 17 November 2020; Accepted: 9 December 2020; Published: 11 December 2020 Abstract: Modern terran life uses several essential biopolymers like nucleic acids, proteins and polysaccharides. The nucleic acids, DNA and RNA are arguably life’s most important, acting as the stores and translators of genetic information contained in their base sequences, which ultimately manifest themselves in the amino acid sequences of proteins. But just what is it about their structures; an aromatic heterocyclic base appended to a (five-atom ring) sugar-phosphate backbone that enables them to carry out these functions with such high fidelity? In the past three decades, leading chemists have created in their laboratories synthetic analogues of nucleic acids which differ from their natural counterparts in three key areas as follows: (a) replacement of the phosphate moiety with an uncharged analogue, (b) replacement of the pentose sugars ribose and deoxyribose with alternative acyclic, pentose and hexose derivatives and, finally, (c) replacement of the two heterocyclic base pairs adenine/thymine and guanine/cytosine with non-standard analogues that obey the Watson–Crick pairing rules. -
PNA-Based Graphene Oxide/Porous Silicon Hybrid Biosensor: Towards a Label-Free Optical Assay for Brugada Syndrome
nanomaterials Article PNA-Based Graphene Oxide/Porous Silicon Hybrid Biosensor: Towards a Label-Free Optical Assay for Brugada Syndrome Rosalba Moretta 1, Monica Terracciano 2,* , Nicola Borbone 2 , Giorgia Oliviero 3, Chiara Schiattarella 4, Gennaro Piccialli 2, Andrea Patrizia Falanga 3, Maria Marzano 5, Principia Dardano 1, Luca De Stefano 1,* and Ilaria Rea 1 1 Institute of Applied Sciences and Intelligent Systems, National Research Council, 80131 Naples, Italy; [email protected] (R.M.); [email protected] (P.D.); [email protected] (I.R.) 2 Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy; [email protected] (N.B.); [email protected] (G.P.) 3 Department of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, 80131 Naples, Italy; [email protected] (G.O.); [email protected] (A.P.F.) 4 Department of Physics “E. Pancini”, University of Naples Federico II, 80126 Naples, Italy; [email protected] 5 Institute of Crystallography, National Research Council, 70126 Bari, Italy; [email protected] * Correspondence: [email protected] (M.T.); [email protected] (L.D.S.); Tel.: +39-081-678521 (M.T.); +39-081-6132594 (L.D.S.) Received: 12 October 2020; Accepted: 6 November 2020; Published: 10 November 2020 Abstract: Peptide nucleic acid (PNA) is a synthetic DNA mimic that outperforms the properties of traditional oligonucleotides (ONs). On account of its outstanding features, such as remarkable binding affinity towards complementary DNA or RNA as well as high thermal and chemical stability, PNA has been proposed as a valuable alternative to the ON probe in gene-sensor design. -
Conformation and Polymorphism in PNA-DNA and PNA-RNA Hybrids (Chimera/Duplex/Triple Helix/Molecular Mechanics)
Proc. Natl. Acad. Sci. USA Vol. 90, pp. 9542-9546, October 1993 Biochemistry Peptide nucleic acid (PNA) conformation and polymorphism in PNA-DNA and PNA-RNA hybrids (chimera/duplex/triple helix/molecular mechanics) ORN ALMARSSON AND THOMAS C. BRUICE Department of Chemistry, University of California at Santa Barbara, Santa Barbara, CA 93106 Contributed by Thomas C. Bruice, July 19, 1993 ABSTRACT Two hydrogen-bonding motifs have been pro- nucleic acids, is their stability toward nucleases. Although the posed to account for the extraordinary stability of polyamide designing of the PNA analogues of DNA has been described "peptide" nucleic acid (PNA) hybrids with nucleic acids. These by the inventors (4), the design rationale does not explain the interresidue- and intraresidue-hydrogen-bond motifs were in- great stability of the PNA hybrids with nucleic acids, as vestigated by molecular mechanics calculations. Energy- exemplified by PNA-strand invasion of double-helical DNA. iinimized structures of Watson-Crick base-paired decameric Our recent molecular mechanics study (5) with the B-helix duplexes of PNA with A-, B-, and Z-DNA and A-RNA poly- structure of the DNA*PNA duplex (dAp)lo'(pnaT)lo [where morphs indicate that the inherent stability of the complemen- (dAp)10 is the decanucleotide of 2'-deoxyadenosine 5'- tary PNA helical structures is derived from interresidue, rather phosphate and (pnaT)lo is the decamer of thyminyl PNA with than from intraresidue, hydrogen bonds in all hybrids studied. lysine amide attached to the C terminus] strongly suggests that Intraresidue-hydrogen-bond lengths are consistently longer the stability of DNA*PNA duplexes is due to interresidue than interresidue hydrogen bonds. -
Dna Enzymes for Peptide-Nucleic Acid Conjugation and for Lysine Methylation
DNA ENZYMES FOR PEPTIDE-NUCLEIC ACID CONJUGATION AND FOR LYSINE METHYLATION BY CHIH-CHI CHU DISSERTATION Submitted in partial fulfillment of the requirements for the degree of Doctor of Philosophy in Chemistry in the Graduate College of the University of Illinois at Urbana-Champaign, 2017 Urbana, Illinois Doctoral Committee: Professor Scott K. Silverman, Chair Professor Paul J. Hergenrother Associate Professor Douglas A. Mitchell Professor Steven C. Zimmerman Abstract Proteins and RNA are known to be enzymes in nature. These biopolymers have complex secondary and tertiary structures that can enable substrate binding and catalysis. DNA is primarily double-stranded and is not known to be catalytic in nature. However, given the similarities in chemical structure between DNA and RNA, it is reasonable to think that single- stranded DNA can also form complex structures. In fact, artificial DNA enzymes have been identified in laboratories by in vitro selection. The identification of new enzymes favors the use of nucleic acids over proteins for several reasons. First, nucleic acids can be amplified by natural enzymes whereas proteins cannot be amplified in any way. Second, the number of possible sequences is smaller for nucleic acids (4n, where n is the length of the biopolymer) than for proteins (20n). Therefore, selection experiments for identifying nucleic acid enzymes will cover a larger fraction of total sequence space. Furthermore, of the sequence space that is covered, a large portion of nucleic acid sequences can fold into secondary or tertiary structures, whereas most random sequences of proteins often will not fold and thus will aggregate. Between the two nucleic acid polymers, DNA offers additional advantages over RNA because DNA can be directly amplified by polymerases whereas RNA requires an extra reverse transcription step. -
12.12.2017 1 CHAPTER 1 OLIGONUCLEOTIDES Part 2
12.12.2017 Canonical nucleobase pairing and alternative base pairs CHAPTER 1 OLIGONUCLEOTIDES Part 2 – noncanonical nucleobases Natural and non-natural base pairs that function in polymerase reactions Self-assembly of whole genes and DNA nanostructures The technology tested by assembly of the kanamycin-resistance gene and growing the bacteria in the environment containing kanamycin after assembly and conversion of that gene. S. Benner et al., Beilstein J. Org. Chem. 2014, 10, 2348–2360. doi:10.3762/bjoc.10.245 1 12.12.2017 AEGIS – Artificially Expanded Genetic Information System AEGIS – Artificially Expanded Genetic Information System ZP CG S. Benner et al., Beilstein J. Org. Chem. 2014, 10, 2348–2360. doi:10.3762/bjoc.10.245 S. Benner et al., J. Am. Chem. Soc., 2011 , 133 (38), pp 15105–15112 AEGIS – Permanent orthogonal nucleobases surviving PCR ACGTZP-DNA crystal structures Electron density presented to the minor groove recognition site by polymerases „ minor groove scanning hypothesis” Error rate 0,2% per a PCR cycle – both removal and incorporation of Z and P the artificial genetic system capable to evolve. Pol: Deep Vent – 2 Z/P, Taq/Phu – 3-4 Z/P 18-mers: 2+2 Z:P pairs B-DNA dZTP ( deprotonated ) at higher pH pairs slightly with G 6 consecutive Z:P A-DNA loss of some Z, but also gain of some new Z mutants. 0,1 nm wider, but otherwise alike G:C pairs S. Benner et al., J. Am. Chem. Soc., 2011 , 133 (38), pp 15105–15112 S. Benner et al., J. Am. Chem. Soc., 2015, 137, pp 6947–6955 2 12.12.2017 Unnatural aminoacid incorporation using a noncanonical base pair (A) The coupled transcription–translation system using the nonstandard codon– anticodon interaction for the site-specific incorporation of 3-chlorotyrosine into the Ras protein. -
Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on Sirna † † † † † Mark K
Article pubs.acs.org/JACS Chirality Dependent Potency Enhancement and Structural Impact of Glycol Nucleic Acid Modification on siRNA † † † † † Mark K. Schlegel,*, Donald J. Foster, Alexander V. Kel’in, Ivan Zlatev, Anna Bisbe, † † # † † ‡ Muthusamy Jayaraman, Jeremy G. Lackey, , Kallanthottathil G. Rajeev, Klaus Charisse,́Joel Harp, ‡ † ‡ † Pradeep S. Pallan, Martin A. Maier, Martin Egli, and Muthiah Manoharan*, † Alnylam Pharmaceuticals, 300 Third Street, Cambridge, Massachusetts 02142, United States ‡ Vanderbilt University School of Medicine, Department of Biochemistry, Nashville, Tennessee 37232, United States *S Supporting Information ABSTRACT: Here we report the investigation of glycol nucleic acid (GNA), an acyclic nucleic acid analogue, as a modification of siRNA duplexes. We evaluated the impact of (S)- or (R)-GNA nucleotide incorporation on RNA duplex structure by determining three individual crystal structures. These structures indicate that the (S)-nucleotide backbone adopts a conformation that has little impact on the overall duplex structure, while the (R)-nucleotide disrupts the phosphate backbone and hydrogen bonding of an adjacent base pair. In addition, the GNA-T nucleobase adopts a rotated conformation in which the 5-methyl group points into the minor groove, rather than the major groove as in a normal Watson−Crick base pair. This observation of reverse Watson−Crick base pairing is further supported by thermal melting analysis of GNA-C and GNA-G containing duplexes where it was demonstrated that a higher thermal stability was associated with isoguanine and isocytosine base pairing, respectively, over the canonical nucleobases. Furthermore, it was also shown that GNA nucleotide or dinucleotide incorporation increases resistance against snake venom phosphodiesterase. Consistent with the structural data, modification of an siRNA with (S)-GNA resulted in greater in vitro potencies over identical sequences containing (R)-GNA.